Scholarlink

<p>Vitiligo is a multifactorial depigmenting disorder characterized by melanocyte loss, oxidative stress, and impaired melanogenesis. Resveratrol (RVT) exhibits potent antioxidant and cytoprotective properties; however, its topical application is limited by its&#xa0;poor cutaneous penetration, rapid degradation, and limited local bioavilability. To overcome these limitations, we developed a resveratrol-loaded novasomal formulation (RVT-NVS) and evaluated its physicochemical properties,&#xa0;in vitro release behavior,&#xa0;repigmentation efficacy in a 40%&#xa0;monobenzone&#xa0;(MZ)-induced vitiligo-like depigmentation&#xa0;model in black chicks. Dermal tolerability was additionally assessed in rats. RVT-NVS exhibited nanoscale vesicles with an average size of&#xa0;386&#xa0;nm, a a relatively&#xa0;narrow size distribution (PDI&#xa0;= 0.31), high entrapment efficiency of&#xa0;79%, and a&#xa0;negative zeta potential of&#xa0;− 37&#xa0;mV. The RVT-NVS gel showed sustained RVT release over 12 h compared with the free RVT gel.&#xa0;MZ induced marked depigmentation, hematological alterations, reduced body weight gain, histopathological skin damage, reduced tyrosinase immunoreactivity, and altered behavioral readouts. RVT-NVS significantly improved visible&#xa0;repigmentation, normalized hematological parameters, improved body weight&#xa0;gain, preserved epidermal and feather follicle architecture, and restored tyrosinase-positive melanocyte-associated staining more effectively than free RVT, blank nanovehicle, or natural composite formulations. RVT-NVS also improved several MZ-associated behavioral readouts, including sweet-solution consumption, locomotor activity, social-response measures, freezing behavior, and tonic immobility duration. Molecular docking suggested possible interactions of RVT with targets related to redox regulation, melanogenesis, inflammation, and apoptosis, with favorable predicted interactions observed for catalase (CAT)&#xa0;and selected melanogenesis-associated targets. These findings suggest that RVT-NVS may represent a promising nanoscale topical delivery system for chemically induced oxidative melanocyte injury and vitiligo-like depigmentation.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Resveratrol-loaded novasomal gel for sustained dermal delivery against monobenzone-induced vitiligo-like depigmentation in black chicks

  • 期刊论文

  • 发表日期：

    2026年6月28日

查看全文
  • Fatma I. Abo El-Ela,
  • Hussein M. Eid,
  • Walid Hamdy Hassan,
  • Rasha Ragab Ibrahim,
  • Abdel-Razik H. Abdel-Razik,
  • Salwa Baroni,
  • Mary Eskander Attia,
  • Ahmed G. Soliman,
  • Ahmed G. K. Habib

摘要

Vitiligo is a multifactorial depigmenting disorder characterized by melanocyte loss, oxidative stress, and impaired melanogenesis. Resveratrol (RVT) exhibits potent antioxidant and cytoprotective properties; however, its topical application is limited by its poor cutaneous penetration, rapid degradation, and limited local bioavilability. To overcome these limitations, we developed a resveratrol-loaded novasomal formulation (RVT-NVS) and evaluated its physicochemical properties, in vitro release behavior, repigmentation efficacy in a 40% monobenzone (MZ)-induced vitiligo-like depigmentation model in black chicks. Dermal tolerability was additionally assessed in rats. RVT-NVS exhibited nanoscale vesicles with an average size of 386 nm, a a relatively narrow size distribution (PDI = 0.31), high entrapment efficiency of 79%, and a negative zeta potential of − 37 mV. The RVT-NVS gel showed sustained RVT release over 12 h compared with the free RVT gel. MZ induced marked depigmentation, hematological alterations, reduced body weight gain, histopathological skin damage, reduced tyrosinase immunoreactivity, and altered behavioral readouts. RVT-NVS significantly improved visible repigmentation, normalized hematological parameters, improved body weight gain, preserved epidermal and feather follicle architecture, and restored tyrosinase-positive melanocyte-associated staining more effectively than free RVT, blank nanovehicle, or natural composite formulations. RVT-NVS also improved several MZ-associated behavioral readouts, including sweet-solution consumption, locomotor activity, social-response measures, freezing behavior, and tonic immobility duration. Molecular docking suggested possible interactions of RVT with targets related to redox regulation, melanogenesis, inflammation, and apoptosis, with favorable predicted interactions observed for catalase (CAT) and selected melanogenesis-associated targets. These findings suggest that RVT-NVS may represent a promising nanoscale topical delivery system for chemically induced oxidative melanocyte injury and vitiligo-like depigmentation.

Graphical Abstract